Antiarrhythmic Pharmacogenomics and Cardiovascular Health in Women

LI Cui-lan,HU Da-yi
DOI: https://doi.org/10.3969/j.issn.1004-3934.2012.05.005
2012-01-01
Abstract:The article reviews the latest progress related to antiarrhythmic pharmacogenomics and cardiovascular diseases and health for women.It includes:(1) basic concepts;(2) cytochrome P450 polymorphisms and antiarrhythmic drugs;(3) polymorphisms coding ion channels and arrhythmias;(4) gender differences of expression for ion channel and transfer subunits;(5) gender differences of ventricular repolarization;(6) gender differences of inherrited and drug-induced long QT syndrome and treatment strategy;(7) selective estrogen receptor modulator raloxifene and QT interval;(8) the additive effects of naringenin and antiarrhythmic drug.
What problem does this paper attempt to address?